A new medical technology expected to be on the market in 2027 is poised to help patients in middle America have greater access to heart transplants. Xvivo Perfusion, a leader in organ transplant ...

A new report suggests that millions of U.S. adults are unaware they may have undiagnosed cardiovascular risk factors that ...

Despite substantial advances in guideline-directed medical therapy, recurrent hospitalization remains a persistent challenge in the management of congestive heart failure (CHF). Fluid overload is ...

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. TransMedics Group (NasdaqGM:TMDX) received full FDA approval for its ...

Organ donation after the heart stops beating has risen sharply in the U.S. Over 25 years, it has grown from a rare practice ...

Organ transplantation is the most effective therapy for patients with end-stage disease. Preservation solutions and techniques are crucial for donor organ quality, which is directly related to ...

Naples, Fla., March 12, 2026 (GLOBE NEWSWIRE)-- Naples Comprehensive Health (NCH) today announced plans to expand its premier cardiovascular service to include the foundation of an Advanced Heart ...

TransMedics Group recently received full FDA approval for its Next-Generation OCS ENHANCE Heart Investigational Device Exemption trial, advancing efforts to validate prolonged heart perfusion and ...

Organ donation after the heart stops beating, a practice called donation after circulatory death, has gone from rare to ...

The family of an 8-year-old girl with a rare heart defect is using their journey to support other families in the same ...